Shoulder Innovations, Inc. (NYSE:SI - Get Free Report) major shareholder Healthcare Holding B.V. Gilde sold 20,034 shares of the company's stock in a transaction dated Friday, July 31st. The stock was sold at an average price of $22.73, for a total value of $455,372.82. Following the completion of the transaction, the insider directly owned 2,332,203 shares in the company, valued at approximately $53,010,974.19. The trade was a 0.85% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Large shareholders that own 10% or more of a company's shares are required to disclose their sales and purchases with the SEC.
Healthcare Holding B.V. Gilde also recently made the following trade(s):
- On Thursday, July 30th, Healthcare Holding B.V. Gilde sold 28,245 shares of Shoulder Innovations stock. The shares were sold at an average price of $23.36, for a total value of $659,803.20.
Shoulder Innovations Trading Down 1.4%
NYSE:SI opened at $22.41 on Tuesday. The company has a market capitalization of $464.89 million and a P/E ratio of -0.13. The stock's 50 day moving average price is $19.34 and its 200 day moving average price is $15.86. The company has a debt-to-equity ratio of 0.11, a quick ratio of 10.04 and a current ratio of 11.81. Shoulder Innovations, Inc. has a 52 week low of $10.92 and a 52 week high of $24.59.
Shoulder Innovations (NYSE:SI - Get Free Report) last posted its earnings results on Wednesday, May 13th. The company reported ($0.41) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.44) by $0.03. Shoulder Innovations had a negative net margin of 81.78% and a negative return on equity of 35.11%. The firm had revenue of $16.71 million during the quarter. On average, research analysts forecast that Shoulder Innovations, Inc. will post -1.67 EPS for the current fiscal year.
Institutional Trading of Shoulder Innovations
Institutional investors and hedge funds have recently modified their holdings of the company. Sectoral Asset Management Inc. boosted its holdings in shares of Shoulder Innovations by 14.4% during the 4th quarter. Sectoral Asset Management Inc. now owns 492,435 shares of the company's stock worth $7,042,000 after buying an additional 62,153 shares during the period. Deerfield Management Company L.P. acquired a new position in Shoulder Innovations during the 3rd quarter worth $6,056,000. Alyeska Investment Group L.P. bought a new stake in Shoulder Innovations during the third quarter valued at about $5,667,000. Roubaix Capital LLC grew its position in shares of Shoulder Innovations by 61.9% in the first quarter. Roubaix Capital LLC now owns 257,121 shares of the company's stock valued at $3,736,000 after purchasing an additional 98,305 shares during the last quarter. Finally, Vanguard Group Inc. bought a new position in shares of Shoulder Innovations in the third quarter worth about $1,836,000.
Wall Street Analysts Forecast Growth
Several equities analysts have commented on SI shares. UBS Group started coverage on shares of Shoulder Innovations in a research report on Tuesday, July 28th. They set a "buy" rating and a $27.00 target price on the stock. Piper Sandler reaffirmed an "overweight" rating and issued a $19.00 price target (up from $18.00) on shares of Shoulder Innovations in a research report on Friday, May 8th. Finally, Weiss Ratings reiterated a "sell (d-)" rating on shares of Shoulder Innovations in a research note on Monday, June 29th. Six equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $22.00.
Check Out Our Latest Stock Report on SI
About Shoulder Innovations
(
Get Free Report)
Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.
In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
